Prescribe RHAPSIDO using one of two pathways:

Insurance support

Help navigating the insurance process, including benefits verification and support with the prior authorization and appeals processes.

Benefits verification

Once you’ve enrolled your patients in Novartis Patient Support, our team will conduct a benefits verification to better understand your patient’s coverage, including:

• Informing your practice about additional requirements, such as prior authorization

• Identifying savings options available to your patients

Prior authorizations (PAs) and appeals

Novartis Patient Support can help with PA requests or letters of appeal by working directly with you or your office, including:

• Providing helpful information and timely updates via phone

• PA and Appeals Kit that includes the following:

  • PA checklist

  • Exception request checklist

  • Appeal submission checklist

  • Sample letters

Financial support

Assist with connecting patients to relevant savings options.

At Novartis Patient Support, we understand that affordability is important. That’s why we offer a range of savings options and resources to help your patients access treatment regardless of their ability to pay.

Up to 12 months of RHAPSIDO for free. Eligible patients whose insurance coverage is delayed or denied can start treatment while health plan coverage is pursued. 

To sign up for the $0 Co-Pay Plus offer*:

*Limitations apply. Valid only for those with private insurance. The Program includes the Co-Pay Plus offer, Plus Card (if applicable), and Rebate, with a combined annual limit. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited toward patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.
^†The Bridge Program applies to RHAPSIDO^® only. Eligible patients must have private insurance and a valid prescription for RHAPSIDO, and a delay or denial of coverage. Program requires the submission of a prior authorization or an appeal of the coverage denial within the first 90 days of enrollment to remain eligible. Program provides RHAPSIDO for free to eligible patients for up to 12 months, or until they receive insurance coverage approval, whichever occurs earlier. A valid prescription consistent with FDA-approved labeling is required. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Patients may be asked to reverify insurance coverage status during the course of the program. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Additional limitations may apply. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this Program without notice.

Novartis Patient Support provides patients with ongoing help to stay on track with their RHAPSIDO treatment plan, including:

• A dedicated Novartis Patient Support Team member to answer their questions at every step

• Information on financial support options

• Help navigating health care changes

• Tips for setting up a routine that keeps them on track with their medication dosing

• Resources for living with chronic spontaneous urticaria (CSU), administering RHAPSIDO, and finding supportive communities

• Continuous support to answer lifestyle and routine questions

• Their choice of texts, calls, and emails, including tips to keep them on track

Novartis Patient Support does not provide clinical advice or care and is not a substitute for patient consultation with a health care provider.

Novartis Patient Assistance Foundation, Inc. (NPAF), an independent 501(c)(3) non-profit organization, provides Novartis medications free of cost to eligible patients who have limited or no prescription insurance coverage and cannot afford the cost of their medication.

To be eligible, your patients must:

• Reside in the United States or a US Territory

• Be treated by a licensed US health care provider on an outpatient basis

• Meet income and insurance guidelines